Biotheranostics Announces Inclusion of Breast Cancer Index in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy San Diego, CA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Breast Cancer Index™ (BCI) has reached an incredible milestone as a new standard of care to predict benefit from extended endocrine therapy for...

Biotheranostics Launches Not Another Minute Campaign for its Breast Cancer Index® Test San Diego, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for...